Literature DB >> 11461902

1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase.

L M Sly1, M Lopez, W M Nauseef, N E Reiner.   

Abstract

We investigated the basis for the induction of monocyte antimycobacterial activity by 1alpha,25-dihydroxyvitamin D(3) (D(3)). As expected, incubation of Mycobacterium tuberculosis-infected THP-1 cells or human peripheral blood, monocyte-derived macrophages with hormone resulted in the induction of antimycobacterial activity. This effect was significantly abrogated by pretreatment of cells with either of the phosphatidylinositol 3-kinase (PI 3-K) inhibitors, wortmannin or LY294002, or with antisense oligonucleotides to the p110 subunit of PI 3-Kalpha. Cells infected with M. tuberculosis alone or incubated with D(3) alone produced little or undetectable amounts of superoxide anion (O(2)). In contrast, exposure of M. tuberculosis-infected cells to D(3) led to significant production of O(2), and this response was eliminated by either wortmannin, LY294002, or p110 antisense oligonucleotides. As was observed for PI 3-K inactivation, the reactive oxygen intermediate scavenger, 4-hydroxy-TEMPO, and degradative enzymes, polyethylene glycol coupled to either superoxide dismutase or catalase, also abrogated D(3)-induced antimycobacterial activity. Superoxide production by THP-1 cells in response to D(3) required prior infection with live M. tuberculosis, since exposure of cells to either killed M. tuberculosis or latex beads did not prime for an oxidative burst in response to subsequent hormone treatment. Consistent with these findings, redistribution of the cytosolic oxidase components p47(phox) and p67(phox) to the membrane fraction was observed in cells incubated with live M. tuberculosis and D(3) but not in response to combined treatment with heat-killed M. tuberculosis followed by D(3). Redistribution of p47(phox) and p67(phox) to the membrane fraction in response to live M. tuberculosis and D(3) was also abrogated under conditions where PI 3-K was inactivated. Taken together, these results indicate that D(3)-induced, human monocyte antimycobacterial activity is regulated by PI 3-K and mediated by the NADPH-dependent phagocyte oxidase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461902     DOI: 10.1074/jbc.M102876200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

Review 1.  Immunomodulation by vitamin D: implications for TB.

Authors:  Rene F Chun; John S Adams; Martin Hewison
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

2.  Vitamin d deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells.

Authors:  Marija Djukic; Marie Luise Onken; Sandra Schütze; Sandra Redlich; Alexander Götz; Uwe-Karsten Hanisch; Thomas Bertsch; Sandra Ribes; Andrea Hanenberg; Simon Schneider; Cornelius Bollheimer; Cornel Sieber; Roland Nau
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection.

Authors:  Emanuela Greco; Gianluca Quintiliani; Marilina B Santucci; Annalucia Serafino; Anna Rita Ciccaglione; Cinzia Marcantonio; Massimiliano Papi; Giuseppe Maulucci; Giovanni Delogu; Angelo Martino; Delia Goletti; Loredana Sarmati; Massimo Andreoni; Alfonso Altieri; Mario Alma; Nadia Caccamo; Diana Di Liberto; Marco De Spirito; Nigel D Savage; Roberto Nisini; Francesco Dieli; Tom H Ottenhoff; Maurizio Fraziano
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-25       Impact factor: 11.205

4.  Differential regulation of interleukin-12 and tumour necrosis factor-alpha by phosphatidylinositol 3-kinase and ERK 1/2 pathways during Mycobacterium tuberculosis infection.

Authors:  C-S Yang; J-S Lee; S-B Jung; J-H Oh; C-H Song; H-J Kim; J-K Park; T-H Paik; E-K Jo
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

5.  Vitamin D and immune function: understanding common pathways.

Authors:  Daniel D Bikle
Journal:  Curr Osteoporos Rep       Date:  2009-07       Impact factor: 5.096

6.  Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals.

Authors:  Florence Momplaisir; Ian Frank; Wa Meyer; Deborah Kim; Rosemary Kappes; Pablo Tebas
Journal:  J AIDS Clin Res       Date:  2012-05-20

7.  Vitamin D rescues impaired Mycobacterium tuberculosis-mediated tumor necrosis factor release in macrophages of HIV-seropositive individuals through an enhanced Toll-like receptor signaling pathway in vitro.

Authors:  Asha Anandaiah; Sanjeev Sinha; Medhavi Bole; Surendra K Sharma; Narendra Kumar; Kalpana Luthra; Xin Li; Xiuqin Zhou; Benjamin Nelson; Xinbing Han; Souvenir D Tachado; Naimish R Patel; Henry Koziel
Journal:  Infect Immun       Date:  2012-10-15       Impact factor: 3.441

Review 8.  Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials.

Authors:  Alexandra V Yamshchikov; Nirali S Desai; Henry M Blumberg; Thomas R Ziegler; Vin Tangpricha
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

Review 9.  Review article: vitamin D and inflammatory bowel diseases.

Authors:  V P Mouli; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

10.  Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses.

Authors:  Philip T Liu; Mirjam Schenk; Valencia P Walker; Paul W Dempsey; Melissa Kanchanapoomi; Matthew Wheelwright; Aria Vazirnia; Xiaoran Zhang; Andreas Steinmeyer; Ulrich Zügel; Bruce W Hollis; Genhong Cheng; Robert L Modlin
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.